Search for content, post, videos

InfiCure attracts international attention

inficure

The fibrosis model offered by Umeå based company InfiCure is attracting international attention and last month the startup signed their first contract for a full-service preclinical pilot study to test two substances for an american client in Boston. The trial i currently underway, with all lab work beeing done on location in Umeå.

Late October, InfiCure Bio signed up for collaboration with their first ever international client – a life sciences company situated in Boston, USA. Currently, lab work is underway in Umeå to complete and deliver the first order abroad.

The order is for a full-service preclinical trial of two substances with potential to affect fibrosis – or scar tissue formation in organs due to long lasting inflammation. As there is a limited number of model systems available for fibrosis studies. The shortage of preclinical testing systems makes the whole organism-model offered by InfiCure Bio an attractive option.

Besides increasing Inficure’s credibility as a professional trail service partner, the international order gives the emplyees a well deserved boost in motivation. Sofia Mayans, CEO at InfiCure Bio, is please with the project so far.

The project is expected to take around a month to complete. If the substances perform well, further collaboration may be in stora – as this first order is a pilot study.

Leave a Reply

Your email address will not be published. Required fields are marked *

four × one =